Paul Zivich

Paul Zivich

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2020 in Annual Review of Public Health
Verified
Journal Article
Open access
AAAllison E. Aiello
Allison E. Aiello
ARAudrey Renson
Audrey Renson
PZPaul Zivich
Paul Zivich
Disease surveillance systems are a cornerstone of public health tracking and prevention. This review addresses the use, promise, perils, and ethics of social media– and Internet-based data collection for public health surveillance. Our review highlights untapped opportunities for integrating digital surveillance in public health and current applications that could be improved through better integration, validation, and clarity on rules surrounding ethical considerations. Promising developments include hybrid systems that couple traditional surveillance data with data from search queries, social media posts, and crowdsourcing. In the future, it will be important to identify opportunities for public and private partnerships, train public health experts in data science, reduce biases related to digital data (gathered from Internet use, wearable devices, etc.), and address privacy. We are on the precipice of an unprecedented opportunity to track, predict, and prevent global disease burdens in the population using digital data.

1 May 2021 in Epidemiology
Verified
Journal Article
Closed access
PZPaul Zivich
Paul Zivich
ABAlexander Breskin
Alexander Breskin
Background: Modern causal inference methods allow machine learning to be used to weaken parametric modeling assumptions. However, the use of machine learning may result in complications for inference. Doubly robust cross-fit estimators have been proposed to yield better statistical properties. Methods: We conducted a simulation study to assess the performance of several different estimators for the average causal effect. The data generating mechanisms for the simulated treatment and outcome included log-transforms, polynomial terms, and discontinuities. We compared singly robust estimators (g-computation, inverse probability weighting) and doubly robust estimators (augmented inverse probability weighting, targeted maximum likelihood estimation). We estimated nuisance functions with parametric models and ensemble machine learning separately. We further assessed doubly robust cross-fit estimators. Results: With correctly specified parametric models, all of the estimators were unbiased and confidence intervals achieved nominal coverage. When used with machine learning, the doubly robust cross-fit estimators substantially outperformed all of the other estimators in terms of bias, variance, and confidence interval coverage. Conclusions: Due to the difficulty of properly specifying parametric models in high-dimensional data, doubly robust estimators with ensemble learning and cross-fitting may be the preferred approach for estimation of the average causal effect in most epidemiologic studies. However, these approaches may require larger sample sizes to avoid finite-sample issues.

28 October 2021 in Statistics in Medicine
Verified
Journal Article
Open access
PDF file
MSMatthew J. Smith
Matthew J. Smith
MMMohammad A. Mansournia
Mohammad A. Mansournia
CMCamille Maringe
Camille Maringe
PZPaul Zivich
Paul Zivich
SCStephen R. Cole
Stephen R. Cole
MLMiguel Angel Luque-Fernandez
Miguel Angel Luque-Fernandez
The main purpose of many medical studies is to estimate the effects of a treatment or exposure on an outcome. However, it is not always possible to randomize the study participants to a particular treatment, therefore observational study designs may be used. There are major challenges with observational studies; one of which is confounding. Controlling for confounding is commonly performed by direct adjustment of measured confounders; although, sometimes this approach is suboptimal due to modeling assumptions and misspecification. Recent advances in the field of causal inference have dealt with confounding by building on classical standardization methods. However, these recent advances have progressed quickly with a relative paucity of computational‐oriented applied tutorials contributing to some confusion in the use of these methods among applied researchers. In this tutorial, we show the computational implementation of different causal inference estimators from a historical perspective where new estimators were developed to overcome the limitations of the previous estimators (ie, nonparametric and parametric g‐formula, inverse probability weighting, double‐robust, and data‐adaptive estimators). We illustrate the implementation of different methods using an empirical example from the Connors study based on intensive care medicine, and most importantly, we provide reproducible and commented code in Stata, R, and Python for researchers to adapt in their own observational study. The code can be accessed at https://github.com/migariane/Tutorial_Computational_Causal_Inference_Estimators.

5 November 2018 in Pneumonia
Verified
Journal Article
Open access
PDF file
PZPaul Zivich
Paul Zivich
JGJohn D. Grabenstein
John D. Grabenstein
SBSylvia I. Becker-Dreps
Sylvia I. Becker-Dreps
DWDavid J. Weber
David J. Weber
Streptococcus pneumoniae is capable of causing multiple infectious syndromes and occasionally causes outbreaks. The objective of this review is to update prior outbreak reviews, identify control measures, and comment on transmission. We conducted a review of published S. pneumoniae outbreaks, defined as at least two linked cases of S. pneumoniae. A total of 98 articles (86 respiratory; 8 conjunctivitis; 2 otitis media; 1 surgical site; 1 multiple), detailing 94 unique outbreaks occurring between 1916 to 2017 were identified. Reported serotypes included 1, 2, 3, 4, 5, 7F, 8, 12F, 14, 20, and 23F, and serogroups 6, 9, 15, 19, 22. The median attack rate for pneumococcal outbreaks was 7.0% (Interquartile range: 2.4%, 13%). The median case-fatality ratio was 12.9% (interquartile range: 0%, 29.2%). Age groups most affected by outbreaks were older adults (60.3%) and young adults (34.2%). Outbreaks occurred in crowded settings, such as universities/schools/daycares, military barracks, hospital wards, and long-term care facilities. Of outbreaks that assessed vaccination coverage, low initial vaccination or revaccination coverage was common. Most (73.1%) of reported outbreaks reported non-susceptibility to at least one antibiotic, with non-susceptibility to penicillin (56.0%) and erythromycin (52.6%) being common. Evidence suggests transmission in outbreaks can occur through multiple modes, including carriers, infected individuals, or medical devices. Several cases developed disease shortly after exposure (< 72 h). Respiratory outbreaks used infection prevention (55.6%), prophylactic vaccination (63.5%), and prophylactic antibiotics (50.5%) to prevent future cases. PPSV23 covered all reported outbreak serotypes. PCV13 covered 10 of 16 serotypes. For conjunctival outbreaks, only infection prevention strategies were used. To prevent the initial occurrence of respiratory outbreaks, vaccination and revaccination is likely the best preventive measure. Once an outbreak occurs, vaccination and infection-prevention strategies should be utilized. Antibiotic prophylaxis may be considered for high-risk exposed individuals, but development of antibiotic resistance during outbreaks has been reported. The short period between initial exposure and development of disease indicates that pneumococcal colonization is not a prerequisite for pneumococcal respiratory infection.

12 October 2022 in American Journal of Epidemiology
Verified
Journal Article
Closed access
PDF file
SCStephen R Cole
Stephen R Cole
PZPaul Zivich
Paul Zivich
JEJessie K Edwards
Jessie K Edwards
RRRachael K Ross
Rachael K Ross
BSBonnie Shook-Sa
Bonnie Shook-Sa
JSJeffrey S A Stringer
Jeffrey S A Stringer
Missing data are pandemic and a central problem for epidemiology. Missing data reduce precision and can cause notable bias. There remain too few simple published examples detailing types of missing data and illustrating their possible impact on results. Here we take an example randomized trial that was not subject to missing data and induce missing data to illustrate 4 scenarios in which outcomes are 1) missing completely at random, 2) missing at random with positivity, 3) missing at random without positivity, and 4) missing not at random. We demonstrate that accounting for missing data is generally a better strategy than ignoring missing data, which unfortunately remains a standard approach in epidemiology.

27 November 2023 in Epidemiology
Verified
Journal Article
Closed access
PZPaul Zivich
Paul Zivich
JEJessie K. Edwards
Jessie K. Edwards
ELEric T. Lofgren
Eric T. Lofgren
SCStephen R. Cole
Stephen R. Cole
BSBonnie E. Shook-Sa
Bonnie E. Shook-Sa
JLJustin Lessler
Justin Lessler
Studies designed to estimate the effect of an action in a randomized or observational setting often do not represent a random sample of the desired target population. Instead, estimates from that study can be transported to the target population. However, transportability methods generally rely on a positivity assumption, such that all relevant covariate patterns in the target population are also observed in the study sample. Strict eligibility criteria, particularly in the context of randomized trials, may lead to violations of this assumption. Two common approaches to address positivity violations are restricting the target population and restricting the relevant covariate set. As neither of these restrictions is ideal, we instead propose a synthesis of statistical and simulation models to address positivity violations. We propose corresponding g-computation and inverse probability weighting estimators. The restriction and synthesis approaches to addressing positivity violations are contrasted with a simulation experiment and an illustrative example in the context of sexually transmitted infection testing uptake. In both cases, the proposed synthesis approach accurately addressed the original research question when paired with a thoughtfully selected simulation model. Neither of the restriction approaches was able to accurately address the motivating question. As public health decisions must often be made with imperfect target population information, model synthesis is a viable approach given a combination of empirical data and external information based on the best available knowledge.